Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 32Pain, Postoperative 18Neoplasms 15Parkinson Disease 4, Autosomal Dominant Lewy Body 13Lung Neoplasms 12Brain Neoplasms 12Prostatic Neoplasms 9Ovarian Neoplasms 8Colonic Neoplasms 8Carcinoma, Hepatocellular 8Stomach Neoplasms 7Depression 7Colorectal Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Pain 6Head and Neck Neoplasms 6Thyroid Neoplasms 5Pancreatic Neoplasms 5Multiple Myeloma 5Leiomyoma 5Agnosia 5Neoplasm Metastasis 4Lymphoma 4Fatigue 4Delirium 4Anxiety Disorders 4Urinary Bladder Neoplasms 3Thromboembolism 3Supratentorial Neoplasms 3Stomatitis 3

Interventions

vandetanib 2Thoracoscopy 2Povidone-Iodine 2Cisplatin 2dalotuzumab 1X-Rays 1Ultrasonography 1Tyrosine Kinase Inhibitors 1Tissue Plasminogen Activator 1Tenecteplase 1Saline Solution 1Receptors, Vascular Endothelial Growth Factor 1Pleurodesis 1Pemetrexed 1Octreotide 1Naproxen 1Gemcitabine 1Fentanyl 1Diclofenac 1Deoxyribonucleases 1Dasatinib 1Darbepoetin alfa 1Clinical Laboratory Techniques 1Chest Tubes 1Cdc25C phosphatase (211-221) 1Afatinib 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pleural Effusion × Saline Solution × Clear all
NCT01580618 2026-04-14

Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancy

Kaiser Permanente

Phase 2/3 Terminated
20 enrolled 11 charts
Thoracic

Neoplasms, Pleural Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡